Inhibition of the NF-κB transcriptional activity by protein kinase A

European Journal of Biochemistry

Volumn 269, Issue 18, 2002, Pages 4559-4565

  Takahashi, Naoko ^a   Tetsuka, Toshifumi ^a   Uranishi, Hiroaki ^a   Okamoto, Takashi ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

cAMP; NF B; PKA; Signal transduction

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; ENZYME ACTIVATOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P300; PROTEIN SUBUNIT; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SERINE; SYNAPTOTAGMIN; CREBBP PROTEIN, HUMAN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA BINDING; EMBRYO; ENZYME SUBUNIT; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; TRANSACTIVATION; DRUG ANTAGONISM; GENETIC TRANSCRIPTION; LEUKEMIA CELL LINE; METABOLISM; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION;

CREB-BINDING PROTEIN; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; JURKAT CELLS; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036025166     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2002.03157.x     Document Type: Article

References (35)

1. Baeuerle, P.A. & Baichwal, V.R. (1997) NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv. Immunol. 65, 111-137.
2. Baldwin, A.S. Jr (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683.
3. Ghosh, S., May, M.J. & Kopp, E.B. (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
4. Okamoto, T., Sakurada, S., Yang, J.P. & Merin, J.P. (1997) Regulation of NF-kappa B and disease control: identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-kappa B activation. Curr. Top. Cell Regul. 35, 149-161.
5. Mercurio, F. & Manning, A.M. (1999) Multiple signals converging on NF-kappaB. Curr. Opin. Cell Biol. 11, 226-232.
6. Zandi, E. & Karin, M. (1999) Bridging the gap: Composition, regulation, and physiological function of the IkappaB kinase complex. Mol. Cell Biol. 19, 4547-4551.
7. Gerritsen, M.E., Williams, A.J., Neish, A.S., Moore, S., Shi, Y. & Collins, T. (1997) CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl Acad. Sci. USA 94, 2927-2932.
8. Perkins, N.D., Felzien, L.K., Betts, J.C., Leung, K., Beach, D.H. & Nabel, G.J. (1997) Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275, 523-527.
9. De Cesare, D., Fimia, G.M. & Sassone-Corsi, P. (1999) Signaling routes to CREM and CREB: plasticity in transcriptional activation. Trends Biochem. Sci. 24, 281-285.
10. Taffet, S.M., Singhel, K.J., Overholtzer, J.F. & Shurtleff, S.A. (1989) Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP. Cell Immunol. 120, 291-300.
11. Crutchley, D.J. & Hirsh, M.J. (1991) The stable prostacyclin analog, iloprost, and prostaglandin E1 inhibit monocyte procoagulant activity in vitro. Blood 78, 382-386.
12. Crutchley, D.J., Solomon, D.E. & Conanan, L.B. (1992) Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism. Arterioscler. Thromb. 12, 664-670.
13. De Prost, D., Ollivier, V. & Hakim, J. (1990) Pentoxifylline inhibition of procoagulant activity generated by activated mononuclear phagocytes. Mol. Pharmacol. 38, 562-566.
14. Ollivier, V., Houssaye, S., Ternisien, C., Leon, A., de Verneuil, H., Elbim, C., Mackman, N., Edgington, T.S. & de Prost, D. (1993) Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism. Blood 81, 973-979.
15. Ghersa, P., Hooft van Huijsduijnen, R., Whelan, J., Cambet, Y., Pescini, R. & DeLamarter, J.F. (1994) Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J. Biol. Chem. 269, 29129-29137.
16. Pober, J.S., Slowik, M.R., De Luca, L.G. & Ritchie, A.J. (1993) Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J. Immunol. 150, 5114-5123.
17. Tetsuka, T., Daphna-Iken, D., Miller, B.W., Guan, Z., Baier, L.D. & Morrison, A.R. (1996) Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells. J. Clin. Invest. 97, 2051-2056.
18. Uranishi, H., Tetsuka, T., Yamashita, M., Asamitsu, K., Shimizu, M., Itoh, M. & Okamoto, T. (2001) Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator. J. Biol. Chem. 276, 13395-13401.
19. Okamoto, T., Ogiwara, H., Hayashi, T., Mitsui, A., Kawabe, T. & Yodoi, J. (1992) Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism. Int. Immunol. 4, 811-819.
20. Hayashi, T., Ueno, Y. & Okamoto, T. (1993) Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268, 11380-11388.
21. Yang, J.P., Merin, J.P., Nakano, T., Kato, T., Kitade, Y. & Okamoto, T. (1995) Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro. FEBS Lett. 361, 89-96.
22. Neumann, M., Grieshammer, T., Chuvpilo, S., Kneitz, B., Lohoff, M., Schimpl, A., Franza, B.R. Jr & Serfling, E. (1995) RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J. 14, 1991-2004.
23. Zhong, H., Voll, R.E. & Ghosh, S. (1998) Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell. 1, 661-671.
24. Zhong, H., SuYang, H., Erdjument-Bromage, H., Tempst, P. & Ghosh, S. (1997) The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89, 413-424.
25. Ghersa, P., Whelan, J., Pescini, R., DeLamarter, J.F. & Hooft van Huijsduijnen, R. (1994) Commonly used cat reporter vectors contain a cAMP-inducible, cryptic enhancer that co-operates with NF-kappa B-sites. Gene 151, 331-332.
26. Niehof, M., Manns, M.P. & Trautwein, C. (1997) CREB controls LAP/C/EBP beta transcription. Mol. Cell Biol. 17, 3600-3613.
27. Nalbant, D., Williams, S.C., Stocco, D.M. & Khan, S.A. (1998) Luteinizing hormone-dependent gene regulation in Leydig cells may be mediated by CCAAT/enhancer-binding protein-beta. Endocrinology 139, 272-279.
28. Sirois, J. & Richards, J.S. (1993) Transcriptional regulation of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Evidence for the role of a cis-acting C/EBP beta promoter element. J. Biol. Chem. 268, 21931-21938.
29. Stein, B., Cogswell, P.C. & Baldwin, A.S. Jr (1993) Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell Biol. 13, 3964-3974.
30. Stein, B. & Yang, M.X. (1995) Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol. Cell Biol. 15, 4971-4979.
31. Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T. & Akira, S. (1993) Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl Acad. Sci. USA 90, 10193-10197.
32. Sakurai, H., Chiba, H., Miyoshi, H., Sugita, T. & Toriumi, W. (1999) IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274, 30353-30356.
33. Wang, D. & Baldwin, A.S. Jr (1998) Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. J. Biol. Chem. 273, 29411-29416.
34. Madrid, L.V., Mayo, M.W., Reuther, J.Y. & Baldwin, A.S. Jr (2001) Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276, 18934-18940.
35. 2+/calmodulin-dependent protein kinase IV stimulates nuclear factor-kappa B transactiva-tion via phosphorylation of the p65 subunit. J. Biol. Chem. 276, 20005-20010.